Trademarkia Logo

Canada

C$
TRIERA
FORMALIZED

on 27 Dec 2023

Last Applicant/ Owned by

ZENTEK LTD.

24 Corporate CourtGuelph

ONTARIO

CA

N1G5G5

Serial Number

2301902 filed on 27th Dec 2023

Correspondent Address

MILLER THOMSON LLP

700 West Georgia StreetSuite 2200Vancouver

BRITISH COLUMBIA

CA

V7Y1K8

TRIERA

Trademark usage description

biochemicals, namely, aptamer-encoding nucleic acids for scientific research and medical research; biochemicals, namely, aptamer-encoding nucleic acid Read More

Classification Information


Class [001]
Biochemicals, namely, aptamer-encoding nucleic acids for scientific research and medical research; biochemicals, namely, aptamer-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating infectious diseases, cancers, inflammatory disorders, and immunoregulatory disorders; diagnostic reagents for medical-scientific research use; biochemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; aptamer-encoding nucleic acids for laboratory use


Classification kind code

12

Class [005]
Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating infectious diseases, cancers, inflammatory disorders, and immunoregulatory disorders; medical, biological and pharmaceutical preparations containing aptamer-encoding nucleic acids for the prevention and treatment of infectious diseases, cancers, inflammatory disorders, and immunoregulatory disorders; medical diagnostic reagents


Classification kind code

12

Class [042]
Scientific research in the fields of rapid disease detection diagnostics, pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutic drugs; design, engineering, research, development and testing services in the field of aptamer-encoding nucleic acids


Classification kind code

12

Mark Details


Serial Number

2301902

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 11th Jan 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th Dec 2023
Filed
Submitted for opposition 1
on 27th Dec 2023
Created
Submitted for opposition 31
on 27th Dec 2023
Formalized